Self-treatment of opioid withdrawal with a dietary supplement, Kratom
- PMID: 17882605
- DOI: 10.1080/10550490701525368
Self-treatment of opioid withdrawal with a dietary supplement, Kratom
Erratum in
- Am J Addict. 2007 Nov-Dec;16(6):538. Compton, Wilson [removed]
Abstract
We examined the use of Kratom (Mitragyna sp.), a dietary supplement with mu-opioid agonist activity, by members of a cybercommunity who self-treat chronic pain with opioid analgesics from Internet pharmacies. Within one year, an increase in the number of mentions on Drugbuyers.com, a Web site that facilitates the online purchase of opioid analgesics, suggested that members began managing opioid withdrawal with Kratom. This study demonstrates the rapidity with which information on psychoactive substances disseminates through online communities and suggests that online surveillance may be important to the generation of effective opioid analgesic abuse prevention strategies.
Similar articles
-
Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance.J Addict Med. 2018 Nov/Dec;12(6):481-483. doi: 10.1097/ADM.0000000000000428. J Addict Med. 2018. PMID: 29944481
-
Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth).Addiction. 2008 Jun;103(6):1048-50. doi: 10.1111/j.1360-0443.2008.02209.x. Addiction. 2008. PMID: 18482427 Free PMC article.
-
Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.J Am Osteopath Assoc. 2012 Dec;112(12):792-9. J Am Osteopath Assoc. 2012. PMID: 23212430 Review.
-
Kratom Withdrawal: A Systematic Review with Case Series.J Psychoactive Drugs. 2019 Jan-Mar;51(1):12-18. doi: 10.1080/02791072.2018.1562133. Epub 2019 Jan 5. J Psychoactive Drugs. 2019. PMID: 30614408
-
Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa).J Clin Pharmacol. 2022 May;62(5):577-593. doi: 10.1002/jcph.2001. Epub 2022 Jan 5. J Clin Pharmacol. 2022. PMID: 34775626 Review.
Cited by
-
"Sub is a weird drug:" A web-based study of lay attitudes about use of buprenorphine to self-treat opioid withdrawal symptoms.Am J Addict. 2015 Aug;24(5):403-9. doi: 10.1111/ajad.12213. Epub 2015 May 25. Am J Addict. 2015. PMID: 26009867 Free PMC article.
-
Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.J Med Toxicol. 2018 Dec;14(4):306-322. doi: 10.1007/s13181-018-0685-1. Epub 2018 Oct 30. J Med Toxicol. 2018. PMID: 30377951 Free PMC article. Review.
-
Formation of multiple ion types during MALDI imaging mass spectrometry analysis of Mitragyna speciosa alkaloids in dosed rat brain tissue.Talanta. 2024 Jul 1;274:125923. doi: 10.1016/j.talanta.2024.125923. Epub 2024 Mar 21. Talanta. 2024. PMID: 38569366 Free PMC article.
-
Self-management of buprenorphine/naloxone among online discussion board users.Subst Use Misuse. 2014 Jun;49(8):1017-24. doi: 10.3109/10826084.2014.888449. Subst Use Misuse. 2014. PMID: 24779501 Free PMC article.
-
Kratom (Mitragyna speciosa) use for self-management of pain: Insights from cross-sectional and ecological momentary assessment data.J Pain. 2025 Jan;26:104726. doi: 10.1016/j.jpain.2024.104726. Epub 2024 Nov 4. J Pain. 2025. PMID: 39505119
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials